Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Plos One
|
April 6, 2017
The abundance of the ARL2 GTPase and its GAP, ELMOD2, at mitochondria are modulated by the fusogenic activity of mitofusins and stressors
Laura E Newman, Cara R Schiavon, Chengjing Zhou, et al.
Molecular Biology of the Cell
|
March 10, 2006
Arl2 and Arl3 regulate different microtubule-dependent processes
Chengjing Zhou, Leslie Cunningham, Adam I Marcus, et al.
Journal of Materials Chemistry. B
|
October 1, 2025
Cellulose microfiber-mediated mesoscale architecture promotes the expansion of patient-derived lung cancer organoids while preserving their malignant characteristics
Chengjing Zhou, Jiaxin Wang, Yongming Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
April 19, 2019
Colorectal cancer, radiotherapy and gut microbiota
Shu Zhang, Qiaoxuan Wang, Chengjing Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 11, 2023
Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
Xiaoxue Huang, Chunyan Chen, Weihao Xie, et al.
Molecular Cancer Therapeutics
|
June 29, 2017
A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia
Tamara B Garcia, Jonathan C Snedeker, Dmitry Baturin, et al.
Cancer Communications (London, England)
|
July 30, 2021
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis
Chengjing Zhou, Ting Jiang, Rongzhen Li, et al.
Journal of Cancer Research and Clinical Oncology
|
September 24, 2020
Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals
Chengjing Zhou, Weiwei Xiao, Xiaohao Wang, et al.
Frontiers in Immunology
|
January 3, 2022
Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series
Chengjing Zhou, Ting Jiang, Yajie Xiao, et al.
BMC Cancer
|
December 15, 2021
Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases
Rongzhen Li, Qiaoxuan Wang, Bin Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Plos One
|
April 6, 2017
The abundance of the ARL2 GTPase and its GAP, ELMOD2, at mitochondria are modulated by the fusogenic activity of mitofusins and stressors
Laura E Newman, Cara R Schiavon, Chengjing Zhou, et al.
Molecular Biology of the Cell
|
March 10, 2006
Arl2 and Arl3 regulate different microtubule-dependent processes
Chengjing Zhou, Leslie Cunningham, Adam I Marcus, et al.
Journal of Materials Chemistry. B
|
October 1, 2025
Cellulose microfiber-mediated mesoscale architecture promotes the expansion of patient-derived lung cancer organoids while preserving their malignant characteristics
Chengjing Zhou, Jiaxin Wang, Yongming Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
April 19, 2019
Colorectal cancer, radiotherapy and gut microbiota
Shu Zhang, Qiaoxuan Wang, Chengjing Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 11, 2023
Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
Xiaoxue Huang, Chunyan Chen, Weihao Xie, et al.
Molecular Cancer Therapeutics
|
June 29, 2017
A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia
Tamara B Garcia, Jonathan C Snedeker, Dmitry Baturin, et al.
Cancer Communications (London, England)
|
July 30, 2021
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis
Chengjing Zhou, Ting Jiang, Rongzhen Li, et al.
Journal of Cancer Research and Clinical Oncology
|
September 24, 2020
Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals
Chengjing Zhou, Weiwei Xiao, Xiaohao Wang, et al.
Frontiers in Immunology
|
January 3, 2022
Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series
Chengjing Zhou, Ting Jiang, Yajie Xiao, et al.
BMC Cancer
|
December 15, 2021
Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases
Rongzhen Li, Qiaoxuan Wang, Bin Zhang, et al.
Page
of 2